Semaglutide improved time spent in glycemic range, time below rate and reduced body weight with low rates of hypoglycemia ...

Trade your diet soda for a tall glass of water, a new small-scale study argues. Women were more likely to drop pounds and see ...

CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a ...

This challenge Kickstarts additional investments through the new ADA Innovation Fund CHICAGO, June 21, 2025 /PRNewswire/ -- As the American Diabetes ...

Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of ...

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.

BrightGene Pharmaceutical has scored an early win in its push to topple the big beasts of the GLP-1 field. | BrightGene ...

The safety profile of the therapy was found to be favourable, without any serious adverse events linked to the treatment.

CHICAGO -- Mifepristone (Korlym) reduced HbA1c levels in patients with inadequately controlled type 2 diabetes and ...

will present four peer-reviewed posters at the American Diabetes Association’s (ADA) 85th Scientific Sessions, which will take place June 20–23 in Chicago. These latest poster presentations ...

Endogenex today reported positive findings from studies of its endoscopic procedure aimed at transforming diabetes care.